Chemokine receptors and their antagonists in allergic lung disease

Inflammation Research

Volumn 48, Issue 7, 1999, Pages 353-362

  Wells, T N C ^a   Proudfoot, A E I ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

Antagonists; Chemokines; HIV; Inflammation; Receptors

Indexed keywords

CHEMOKINE RECEPTOR; GLYCOSAMINOGLYCAN; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPID; MEMBRANE PROTEIN;

ALLERGIC DISEASE; HOMEOSTASIS; INFLAMMATION; LEUKOCYTE; LUNG DISEASE; PROTEIN EXPRESSION; REVIEW;

ASTHMA; AUTOIMMUNE DISEASES; CHEMOKINES; GLYCOSAMINOGLYCANS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; RECEPTORS, CHEMOKINE; TH1 CELLS; TH2 CELLS;

EID: 0032802301     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050472     Document Type: Review

References (64)

1. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987; 84: 9233-7.
2. Matsushima K, Larsen CG, DuBois CC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169: 1485-90.
3. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM. Three-dimensional structure of interleukin 8 in solution. Biochemistry 1990; 29: 1689-96.
4. Lubkowski J, Bujacz G, Boque L, Domaille PJ, Handel TM, Wlodawer A. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nature Struct Biol 1997; 4: 64-9.
5. Keiner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, et al. Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994; 266: 1395-9.
6. 3C motif. Nature 1997; 385: 640-4.
7. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997; 387: 611-7.
8. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184:963-9.
9. Wells TNC, Peitsch MC. The chemokine information source: identification and characterization of novel chemokines using the World Wide Web and expressed sequence tag databases. J Leukoc Biol 1997; 61: 545-50.
10. Wells TNC, Power CA, Proudfoot AEI. Definition, function and pathophysiological significance of chemokine receptors. Trends Pharmacol Sci 1998; 19: 376-80.
11. Power CA, Meyer A, Nemeth K, Bacon KB, Hoogewerf AJ, Proudfoot AEI, et al. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995; 270: 19495-500.
12. Hoogewerf A, Black D, Proudfoot AE, Wells TNC, Power CA. Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4. Biochem Biophys Res Commun 1996; 218: 337-43.
13. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997; 272: 15036-042.
14. Leff P, Scaramellini C, Law C, McKechnie K. A three-state receptor model of agonist action. Trends Pharmacol Sci 1997; 18: 355-62.
15. Maggi CA, Schwartz TW. The dual nature of the tachykinin NK1 receptor. Trends Pharmacol Sci 1997; 18: 351-5.
16. Loetscher P, Seitz M, Baggiolini, Moser B. Interleukin-2 regulates CC chemokine recepexpression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996; 184: 569-77.
17. Bonecchi R, Polentarutti N, Luini W, Borsatti A, Bernasconi S, Locati M, et al. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-γ in human neutrophils. J Immunol 1999; 162: 474-9.
18. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian MN, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-9.
19. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AMA, et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88: 661-74.
20. Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AEI, et al. Kinetics of eotaxin generation and its relationship to eosinoohil accumulation in allergic airways disease: Analysis in a guinea pig model in vivo. J Exp Med 1997; 186: 601-12.
21. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J Exp Med 1994; 179: 881-7.
22. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine, eotaxin, to induce eosinophil accumulation in vivo. J Exp Med 1998; 182: 1169-74.
23. Power CA, Church DJ, Meyer A, Alouani S, Proudfoot AEI, Clark-Lewis I, et al. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3α from lung dendritic cells. J Exp Med 1997; 186: 825-35.
24. Greaves DR, Wang W, Dairaghi DJ, Dieu MC, de Saint-Vis B, Franz-Bacon K, et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells. J Exp Med 1997; 186: 837-44.
25. Baba M, Imai T, Nishimura M, Kakizaki M, Tagagi S, Hieshima K, et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 1997; 272: 14893-8.
26. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-73.
27. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 2: 227-57.
28. Schall TJ, Bacon KB, Toy K, Goeddel DV Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-71.
29. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005-7.
30. Proudfoot AEI, Power CA, Hoogewerf AJ, Montjovent MO, Borlat F, Offord RE, et al. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem 1996; 271: 2599-603.
31. Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TNC. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997; 57: 117-20.
32. Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TNC, Salant DJ, et al. JC. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997; 185: 1371-80.
33. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TNC, Proudfoot AEI, et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 1998; 188: 157-67.
34. Teixeira MM, Wells TNC, Lukacs NW, Proudfoot AEI, Kunkel SL, Williams TJ, et al. Chemokine-induced eosinophil recruitment -evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest 1997; 100: 1657-66.
35. Mellor GW, Fogarty SJ, Obrien MS, Congreve M, Banks MN, Mills KM, et al. Searching for chemokine receptor binding antagonists by high throughput screening. J Biomol Screen 1997; 2: 153-7.
36. McKinnon M, Proudfoot AEI, Wells TNC, Solari R. Strategies for the discovery of cytokine receptor antagonists. Drug News Perspect 1996; 9: 389-98.
37. Wells JA, De Vos AM. Hematopoietic receptor complexes. Ann Rev Biochem 1996; 65: 609-34.
38. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, et al. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 1996; 273: 458-64.
39. Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, et al. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 1997; 276: 1696-9.
40. Tian S, Lamb P, King AG, Miller SG, Kessler L, Luengo JI, et al. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science 1998; 281: 257-9.
41. [41 ] White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MAW, et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 1998; 273: 10095-8.
42. Ponath PD. Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS. Exp Opin Invest Drugs 1998; 7: 1-18.
43. Quan JM, Martin TR, Rosenberg GB, Foster DC, Whitmore TGR. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis. Biochem Biophys Res Commun 1996; 219: 405-11.
44. Schols D, Struyf S, Van DJ, Este JA, Henson G, De CE. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997; 186: 1383-8.
45. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 1998; 4: 72-7.
46. Murakami T, Nakajima T, Koyanagi N, Tachibana K, Fujii H, Tamamura N, et al. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med 1997; 186: 1389-93.
47. Doranz BJ, Grovit FK, Sharron MP, Mao SH, Goetz MB, Daar E, et al. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 1997; 186: 1395-1400.
48. Kledal TN, Rosenkilde MM, Schwartz TW. Selective recognition of the membrane bound CX3C chemokine, fractalkine, by the human cytomegalovirus encoded broad spectrum receptor US28. FEBS Lett 1998; 441: 209-14.
49. Hesselgesser JNG, Howard P, Liang M, Zheng W, May K, Bauman JG, et al. Identification and chracterization of small molecule functional antagonists of the CCR1 chemokine receptor. R J Biol Chem 1998; 273: 15687-92.
50. Rot A. Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism. Eur J Immunol 1993; 23: 303-6.
51. Witt DP, Lander AD. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 1994; 4: 394-400.
52. Hoogewerf AJ, Kuschert GS, Proudfoot AE, Borlat F, Clark-Lewis I, Power CA, et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochem 1997; 36: 13570-578.
53. Marquezini MV, Strunz CM, Dallan LA, Toledo OM. Glycosaminoglycan distribution in atherosclerotic saphenous vein grafts. Cardiology 1995; 86: 143-6.
54. Wasty F, Alavi MZ, Moore S. Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 1993; 36: 316-22.
55. Paolini JF, Willard D, Consler T, Luther M, Krangel MS. The chemokines IL-8, monocyte chemoattractant protein-1, and 1-309 are monomers at physiologically relevant concentrations. J Immunol 1994; 153: 2704-17.
56. Burrows SD, Doyle ML, Murphy KP, Franklin SG, White JR, Brooks I, et al. Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochem 1994; 33: 12741-5.
57. Kuschert GS, Hoogewerf AJ, Proudfoot AEI, Chung CW, Cooke R, Hubbard RE, et al. Identification of a glycosoaminoglycan binding site on human interleukin-8. Biochem 1998; 37: 11193-201.
58. Wells TNC, Schwartz TW. Plagiarism of the host immune system - lessons about chemokine immunology from viruses. Curr Opin Biotechnol 1997; 8: 741-8.
59. Gao JL, Murphy PM. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 1994; 269: 28539-42.
60. Persoons MC, Daemen MJ, Bruning JH, Bruggeman CA. Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus-associated atherogenesis? Circ Res 1994; 75: 214-20.
61. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, et al. A broad-spectrum chemokine antagonist encoded by kaposis sarcoma-associated herpesvirus. Science 1997; 277: 1656-9.
62. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart MA, et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 1997; 278: 290-4.
63. Sozzani S, Luini W, Bianchi G, Allavena P, Wells TNC, Napolitano M, et al. A. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 1998; 92: 4036-9.
64. Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol 1998; 160: 624-33.